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Abstract:	   	  
	  
	  The	   authors	   describe	   a	   case	   of	   a	   48-­‐year-­‐old	   man	   who	   presented	   with	   four	   weeks	   of	   fever,	  
generalized	  malaise,	  weight	  loss,	  right	  upper	  quadrant	  abdominal	  pain	  and	  hepatosplenomegaly.	  He	  
evolved	   with	   pancytopenia,	   bone	   marrow	   haemophagocytosis	   and	   hyperferritinaemia.	   Recent	  
diagnosis	  of	  HIV	  infection,	  with	  the	  exclusion	  of	  other	  plausible	  causes,	  prompted	  the	  diagnosis	  of	  
haemophagocytic	  syndrome	  (HPS)	  secondary	  to	  HIV.	  Despite	  intensive	  care	  support	  and	  initiation	  of	  
antiretroviral	   therapy,	   the	   patient	   died.	   HPS	   diagnosis	   secondary	   to	   HIV	   alone	   demands	   the	  
exclusion	  of	  all	  the	  other	  secondary	  causes.	  The	  best	  approach	  includes	  early	  diagnosis	  and	  specific	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Introduction	  
Haemophagocytic	   syndrome	   (HPS)	   is	   a	   rare	   and	   potentially	   fatal	   disorder	   [1].	   Its	   primary	   form	   is	  
associated	  with	   underlying	   genetic	   abnormalities,	   usually	   presenting	   in	   childhood.	   Secondary	   HPS	  
appears	  most	   frequently	   in	  the	  setting	  of	   infection,	  malignancy	  or	  autoimmune	  disease	  [2,	  3].	  This	  
type	  usually	  presents	  in	  adults	  and	  has	  a	  better	  prognosis.	  
Probably	   underestimated,	   secondary	   forms	   are	   still	   being	   identified.	   In	   this	   setting,	   HIV	   has	   been	  
associated	  with	  HPS	  with	   a	  wide	   range	   of	   disorders,	   namely	   viral,	   bacterial,	  mycobacterial,	   fungal	  
and	  protozoal	  infections,	  malignancy,	  autoimmune	  diseases,	  related	  therapy	  and	  even	  HIV	  itself	  [1].	  
The	  diagnostic	  guidelines	  proposed	  by	  the	  Histiocyte	  Society	  have	  contributed	  to	  clarification	  of	  the	  
diagnosis	   [4].	   Naturally,	   the	   diagnosis	   of	   HPS	   secondary	   to	   HIV	   infection	   is	   only	   possible	   in	   the	  
absence	   of	   other	   plausible	   causes.	   The	   authors	   report	   a	   HPS	   secondary	   to	   HIV	   and	   discuss	   some	  
particular	  aspects.	  
	  
Case	  report	   	  
A	  48-­‐year-­‐old	  heterosexual	  man	  was	  admitted	  to	  the	  hospital	  after	  four	  weeks	  of	  fever,	  generalized	  
malaise,	  weight	  loss	  and	  a	  right-­‐upper	  quadrant	  abdominal	  pain.	  Besides	  smoking	  and	  a	  considerable	  
alcohol	   intake	   (80–110	  g/day),	  he	  had	  no	  significant	   travel,	  drug	  or	  medical	  history.	  On	  admission,	  
the	   patient	   appeared	   acutely	   ill,	   with	   mild	   confusion,	   fever	   and	   hypotension,	   without	   other	  
abnormal	   physical	   findings.	   Laboratory	   tests	   (Table	   1)	   showed	   87,000/mm3	   platelets	   (150,000–
400,000/mm3),	  normochromic	  and	  normocytic	  anaemia	  (Hb=7.4	  g/dl),	  lymphopenia	  (860/μl)	  (1500–
4000/mm3),	  elevated	  C-­‐reactive	  protein	  (157	  mg/l)	  (<1.0	  mg/l),	  low	  albumin	  (2.5	  g/dl)	  (3.0–5.0	  g/dl),	  
international	  normalized	  ratio	  (INR)	  of	  1.3	  and	  elevated	  serum	  ferritin	  levels	  (7867	  ng/ml)	  (12.8–454	  
ng/ml).	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Chest	   radiography	   showed	   small	   bilateral	   pleural	   effusions,	   confirmed	   by	   ultrasound,	   which	   also	  
revealed	  homogeneous	  mild	  hepatosplenomegaly	  and	  moderate	  ascites.	  Thoracoabdominal	  CT	  also	  
showed	  diffuse	  lympadenopathy	  (Fig.	  1).	   	  
	  
Peritoneal	   fluid	   was	   tested	   and	   showed	   an	   exudate	   with	   an	   elevated	   mononuclear	   count,	   low	  
adenosine	   deaminase	   and	   negative	   PCR	   for	  Mycobacterium	   tuberculosis.	   HIV	   testing	  was	   positive	  
with	  HIV	  RNA	  of	  101,000	  copies/ml,	  and	  a	  TCD4	  cell	  count	  of	  38/mm3	  (2.4%).	  
Serology	  for	  syphilis,	  Brucella,	  Epstein–Barr	  virus,	  cytomegalovirus,	  Toxoplasma	  gondii	  and	  hepatitis	  
A,	  B	  and	  C	  was	  negative.	   	  
At	   this	   point,	   considering	   the	   recent	   HIV	   diagnosis,	   with	   severe	   immunosuppression	   and	   a	  
presentation	  of	  a	  systemic	  illness	  (haematologic	  findings,	  pleural	  and	  peritoneal	  effusions	  and	  signs	  
of	  activation	  of	  the	  reticuloendothelial	  system),	  haematological	  malignancy,	  tuberculosis	  and	  hepatic	  
disease	  were	  hypothesized	  as	   the	  most	  probable	  differential	  diagnosis.	  Nevertheless,	  a	   sepsis	  also	  
had	   to	   be	   considered	   and	   the	   patient	  was	   admitted	   to	   the	   intermediate	   care	   unit	   and	   started	   on	  
broad-­‐spectrum	  antibiotic	  therapy.	   	   	  
A	   bone	   marrow	   sample	   was	   obtained	   and	   showed	   features	   of	   hypocellularity	   and	  









Figure	   1:	   Thoracoabdominal	   CT	   with	   diffuse	   lympadenopathy	   (<2	   cm)	   and	   homogeneous	   mild	  
hepatosplenomegaly.	  
data	  
Figure	   2:	   Bone	   marrow	   with	   macrophage	  





Doi:	  10.12890/2014_000084	   	   	   	   	   	   	   European	  Journal	  of	  Case	  Reports	  in	  Internal	  Medicine	   	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   ©	  EFIM	  2014	  
The	  analysis	  of	  blood,	  bone	  marrow	  and	   lymph	  node	  tissue	  showed	  no	  sign	  of	   lymphoproliferative	  
disorder	  and	  was	  negative	  for	  bacteria,	  mycobacterium	  and	  fungi.	   	  
On	   the	   fourth	   day	   of	   inpatient	   care,	   despite	   broad-­‐spectrum	   antibiotics,	   the	   clinical	   state	   of	   the	  
patient	   deteriorated	   with	  multiple	   organ	   failure	   and	   he	   was	   admitted	   to	   the	   intensive	   care	   unit,	  
requiring	  vasopressor	  support	  and	  invasive	  mechanical	  ventilation.	   	  
A	  diagnosis	   of	   haemophagocytic	   syndrome,	  most	  probably	   related	   to	  HIV	   infection,	  was	   assumed,	  
since	  no	  evidence	  of	  other	  infection	  or	  haematologic	  disease	  was	  found.	  The	  patient	  was	  started	  on	  
HAART	   (tenofovir,	   emtricitabin,	   lopinavir/ritonavir),	   prednisolone	   (1	   mg/kg	   daily)	   and	  
immunoglobulin	  (1	  g/kg	  for	  two	  consecutive	  days).	  
Haematologic	   dysfunction	   evolved	   with	   deteriorating	   pancytopenia,	   liver	   dysfunction	   with	  
progressive	  hypoalbuminaemia	  and	  hyperbilirubinaemia	  and	  prolongation	  of	  INR.	  He	  also	  developed	  
a	  state	  of	   increased	  vascular	  permeability,	  unresponsive	  to	  albumin	  administration,	  and	  associated	  
refractory	  shock.	   	  
Despite	   all	   the	   above	   treatments,	   the	   patient’s	   clinical	   state	   continued	   to	   deteriorate	   and	   death	  
occurred	  at	  day	  10	  of	  HAART.	   	  
	  
Discussion	  
The	  pathophysiology	  of	  HPS	  is	  best	  understood	  for	  the	  primary	  form	  of	  HPS,	  in	  which	  genetic	  defects	  
in	  proteins	  that	  play	  an	  important	  role	  in	  cytolytic	  secretory	  pathway	  [7]	  lead	  to	  excessive	  activation	  
of	  T	  cells	  and	  subsequently	  to	  increased	  cytokine	  secretion	  and	  hyperactivation	  of	  macrophages	  [1].	  
The	   pathogenesis	   of	   secondary	   HPS	   is	   less	   clear	   and	   in	   the	   setting	   of	   HIV	   infection	   it	   is	   probably	  
related	  to	  acquired	  defects	  in	  cellular	  cytotoxicity	  [1].	   	   	  
Clinical	   features	   of	   HPS	   are	   consistent	  with	   this	   state	   of	   immune	   hyperactivation,	   including	   fever,	  
lymphadenopathy,	   hepatosplenomegaly	   and	   jaundice,	   as	   well	   as	   cytopenia	   and	   impaired	   liver	  
function.	  These	  nonspecific	  features	  have	  a	  wide	  differential	  diagnosis	  in	  the	  context	  of	  HIV.	  Indeed	  
HPS	  may	   be	  mistaken	   for	   many	   other	   disorders,	   most	   frequently	   lymphoproliferative	   diseases	   or	  
infections.	   In	   this	   case	   the	   acute	   clinical	   presentation	   suggested	   a	   septic	   status	   although	  with	   an	  
inconsistent	  evolution	  (no	  response	  to	  broad-­‐spectrum	  antibiotic	  therapy,	  vasopressor	  support	  and	  
albumin	   infusion).	   Efforts	   to	  exclude	   infections	  and	   lymphoproliferative	  disorders	  were	  made.	  The	  
clinical	   findings	   of	   fever,	   hepatosplenomegaly,	   cytopenias,	   bone	   marrow	   haemophagocytosis	   and	  
hyperferritinaemia,	   fulfilled	   five	   of	   the	   above-­‐mentioned	   criteria,	   suggesting	   HPS	   as	   the	   most	  
probable	   diagnosis.	   No	   trigger	   but	   HIV	   was	   found.	   The	  main	   aetiology	   for	   HPS	   in	   HIV	   patients	   is	  
infection.	  In	  the	  largest	  study	  to	  date,	  only	  5%	  of	  patients	  were	  found	  to	  have	  no	  underlying	  cause	  of	  
HPS	  other	  than	  HIV	  itself	  [5].	   	  
The	   proposed	   management	   for	   the	   primary	   form	   of	   HPS,	   the	   HLH-­‐94	   protocol	   [4],	   has	   proven	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infection,	  treatment	  should	  be	  individualized,	  with	  supportive	  care	  promptly	  initiated	  and	  treatment	  
of	   potential	   triggers.	   The	  potential	   efficacy	  of	  HAART	  has	   been	  described	   [1],	   although	   the	   risk	   of	  
immune	   reconstitution	   syndrome	   should	   be	   considered.	   Also,	   high-­‐dose	   corticosteroids	   are	  
commonly	   used	   as	   well	   as	   intravenous	   immunoglobulin	   (IVIg)	   [1].	   In	   this	   case,	   supportive	   care,	  
empiric	   broad-­‐spectrum	   antibiotics,	   corticosteroid	   therapy,	   IVIg	   and	   HAART	  were	   instituted,	   none	  
with	  any	  obvious	  beneficial	  effect.	   	   	   	   	   	   	  
The	  prognosis	  of	  HPS	  was	  significantly	  improved	  after	  HLH-­‐94	  introduction	  for	  primary	  forms	  [15].	  A	  
mortality	   rate	  of	  31%	  at	  3	  months	   for	  HPS	  associated	  with	  HIV	  has	  been	  described	   [5].	  Prognostic	  
factors	   in	   the	  setting	  of	  HPS	  associated	  with	  HIV	  are	  still	   to	  be	   identified,	  although	   ICU	  admission,	  
cytopenias	   and	   haemotological/malignancy-­‐associated	   disorders	   are	   expected	   to	   be	   relevant.	  
Specifically	  related	  to	  HIV,	  low	  CD4	  cell	  count	  is	  expected	  to	  be	  a	  possible	  prognostic	  indicator.	   	  
	  
Conclusion	  
HPS	  diagnosis	   is	  complex	  and	  in	  the	  context	  of	  HIV	  infection	  still	  constitutes	  a	  great	  challenge.	  The	  
best	   approach	   seems	   to	   include	   adequate	   identification	   of	   prognostic	   factors,	   early	   diagnosis	   and	  
specific	  treatment	  of	  the	  associated	  cause,	  whenever	  possible.	   	  
	  
Learning	  Points	  
• HPS	   diagnosis	   is	   complex	   and	   in	   the	   context	   of	   HIV	   infection	   still	   constitutes	   a	   great	  
challenge.	  
• Diagnosis	   of	   HPS	   secondary	   to	   HIV	   alone	   demands	   the	   exclusion	   of	   all	   the	   other	   known	  
secondary	  causes	  of	  HPS.	  
• The	   best	   approach	   to	   treat	   HPS	   includes	   early	   diagnosis,	   adequate	   identification	   of	  
prognostic	  factors,	  supportive	  care	  and	  specific	  treatment	  of	  the	  associated	  cause,	  whenever	  
possible.	   	  
• Consider	  HIV	  as	  a	  possible	  cause	  of	  HPS	  where	  no	  other	  cause	  has	  been	  identified.	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